ArticleDiscover oncology2025

Serum carnitine and cancer risk: a Mendelian randomization study identifying pancreatic cancer as a modifiable metabolic target.

Xiaoqing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.